<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02699528</url>
  </required_header>
  <id_info>
    <org_study_id>MMC-15-0329</org_study_id>
    <nct_id>NCT02699528</nct_id>
  </id_info>
  <brief_title>The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder</brief_title>
  <official_title>Does Methylphenidate, Prescribed for Attention Deficit Disorder, Influence Primary Enuresis in These Children?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess wether methylphenidate reduces the prevalence of primary nocturnal enuresis in
      children with attention deficit disorder
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children aged 5 - 10 years newly diagnosed with attention deficit hyperactivity disorder who
      report primary nocturnal enuresis, Investigators will obtain baseline data (from
      parents/caregivers) on their sleep habits and enuresis characteristics by questionnaire.
      After 6 weeks of methylphenidate therapy, prescribed for the attention deficit, a new
      questionnaire will be filled.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>A reduction in nocturnal enuresis frequency</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Attention Deficit Hyperactivity Disorder</condition>
  <condition>Enuresis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>methylphenidate</intervention_name>
    <description>The drug will be prescribed as indicated for attention deficit disorder</description>
    <other_name>Ritalin, Concerta</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children aged 5 - 10 years receiving a new diagnosis of attention deficit hyperactivity
        disorder
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  New diagnosis of attention deficit hyperactivity disorder

          -  History of primary nocturnal enuresis

          -  Normal neurological examination

        Exclusion Criteria:

          -  Anatomical abnormality of the genitourinary system

          -  Concommitant treatment, pharmacological/behavioral for enuresis

          -  Concommitant diurnal enuresis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathan Watemberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Meir Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Florence Katz, BA</last_name>
    <phone>972-9-7471803</phone>
    <email>florence.katz@clalit.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Omer Raviv, MD</last_name>
    <phone>972-52-8822052</phone>
    <email>omerol@walla.co.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Meir Medical Center</name>
      <address>
        <city>Kfar Saba</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>florence Katz, MA</last_name>
      <phone>972-52-2584081</phone>
      <email>florence.katz@clalit.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Omer Raviv, MD</last_name>
      <phone>972-52-8822052</phone>
      <email>omerol@walla.co.il</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2016</study_first_submitted>
  <study_first_submitted_qc>March 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2016</study_first_posted>
  <last_update_submitted>September 15, 2016</last_update_submitted>
  <last_update_submitted_qc>September 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meir Medical Center</investigator_affiliation>
    <investigator_full_name>Natan Watemberg</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
    <mesh_term>Hyperkinesis</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Nocturnal Enuresis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylphenidate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

